| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |